South San Francisco, CA April 23, 2023 Press Release Genentech Announces Industry-Leading Brain Health Research Collaborations and Latest Data Across Neuroscience Medicines at AAN 2023 Annual Meeting Roche, Genentech and partners embark on global prevalence research, trend-spotting with digital analysis,…
Tag: Genentech
Update on Genentech’s Tecentriq Plus Avastin
South San Francisco, CA April 18, 2023 Press Release Genentech’s Tecentriq Plus Avastin Reduced the Risk of Cancer Returning in People With Certain Types of Adjuvant Liver Cancer in a Phase III Study In the first-ever positive Phase III…
Genentech’s Evrysdi and Types 2 and 3 Spinal Muscular Atrophy Update
South San Francisco, CA March 20, 2023 Press Release New Four-Year Data for Genentech’s Evrysdi Reinforce Long-Term Efficacy and Safety Profile in Some of the Most Severely Affected People With Types 2 and 3 Spinal Muscular Atrophy (SMA) Data…
Genentech and Partners Launch New Open-source Curriculum to Bring Biotechnology Education to Millions of High School Students
South San Francisco, CA September 26, 2022 Press Release Futurelab+ is a $10 Million Expansion of Genentech’s Original South San Francisco Futurelab Program South San Francisco, CA – September 26, 2022 – Genentech, a member of the Roche…
Genentech and Amgen donate to the future of South San Francisco with an emphasis on supporting local youth
South San Francisco, CA February 16, 2021 Press Release As South San Francisco begins construction of the Library, Parks and Recreation Center/Council Chambers on the city’s new Community Civic Campus, Genentech and Amgen Inc. recently announced donations totaling $3.5 million…
Genentech Announces Full FDA Approval for Venclexta Combinations for Acute Myeloid Leukemia
South San Francisco, CA October 17, 2020 Genentech Press Release Approval supported by data from Phase III confirmatory trials, VIALE-A and VIALE-C VIALE-A study showed Venclexta plus azacitidine significantly improved overall survival in newly diagnosed AML compared to azacitidine alone…
Letter to Editor: Old Town Residents Need OUR Input at Planning Commission Meeting Thurs Oct 15th
South San Francisco, CA October 12, 2020 by a native South City Resident Please attend the Planning Commission Meeting Thursday, Oct 15, 2020 07:00 PM Pacific Time (US and Canada) Join Zoom Meeting CLICK HERE Meeting ID: 882 3138 0027…
FDA Approves Genentech’s Gavreto for Treatment of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
South San Francisco, CA September 4, 2020 Submitted by Genentech Genentech Announces FDA Approval of Gavreto (pralsetinib) for the Treatment of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer Gavreto is a once-daily, oral precision therapy that selectively inhibits…
Genentech and the Genentech Foundation Commit $42 Million to Address Immediate and Long-Term Effects of the COVID-19 Pandemic
South San Francisco, CA May 12, 2020 Press Release Genentech and the Genentech Foundation are announcing charitable commitments of $42 million to help address the devastating impact of the COVID-19 pandemic. This support includes emergency response grants as well as…
Genentech COVID-19 Update
South San Francisco, CA March 11,2020 Submitted by Heather Gloe, Genentech Corporate RelationsGen Genentech takes the health and safety of our employees, their families and our local communities very seriously, and we are actively responding to the COVID-19 public health…